Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2
- Type
- Expression of concern
- Notice date
- 9/1/2020 0:00
- Journal
- The Journal of Clinical Investigation (JCI)
- Publisher
- American Society for Clinical Investigation
- Notice DOI
- 10.1172/jci142404
- Original paper DOI
- 10.1172/jci89092